MedPath

Evaluating the potential role of oral activated charcoal as an adjunct treatment for severe bacterial infections and severe malaria - a preliminary safety study

Completed
Conditions
Asymptomatic parasitaemia for Plasmodium falciparum
Infections and Infestations
Registration Number
ISRCTN64793756
Lead Sponsor
Medical Research Council (MRC) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
90
Inclusion Criteria

Healthy African adults aged 15-45 years with asymptomatic parasitaemia confirmed on a thick blood film.

Exclusion Criteria

1. Haemoglobin less than 11 g/dl
2. Detectable levels of chloroquine in the urine
3. Mixed infections
4. Concurrent participation in another study
5. Pregnant or breastfeeding

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath